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Presentation of a clinical case
In October 1993, a 58-year-old man was referred to our hospi-
tal for recurrent calcium urolithiasis. Two of his first-degree rel-
atives suffered from recurrent nephrolithiasis with idiopathic hy-
percalciuria. 
The patient had passed six stones over the past 9 years,
whose composition was calcium oxalate and phosphate. In
1992, he was treated with extracorporeal shock wave lithotrip-
sy in order to remove a 10 mm sized stone from the left kidney,
but the clearance of the fragments was not complete. When
the patient was referred to our Nephrology Unit, he had few
small calcifications in the lower pole of the left kidney and one
little calcification in the higher pole of the right kidney.
Methods
According to our routine approach, biochemistries were per-
formed on serum and urine samples, as follows. 
Serum: total and ionized calcium (Ca), phosphate (PO4), intact
PTH, 25 hydroxyvitamin D (25 Vit D), 1.25 dihydroxyvitamin D
(1.25 Vit D), alkaline phosphatase (ALP). 
Twenty-four hour urine: supersaturations with calcium oxalate
(bCaOx) and calcium phosphate (bbsh), estimated according
to our program (1,2). 
Fasting urine: Ca, creatinine (Cr), hydroxyproline (OHPro). 
Ca excretion per Kg of body weight (Ca/Kg, mg) and Ca to Cr ra-
tio (Ca/Cr, mg/mg) were calculated in 24-hr urine; Ca/Cr and OH-
Pro to Cr ratio (OHPro/Cr, mg/g) were calculated in fasting urine. 
Bone mineral density (BMD) was assessed by dual X-ray ab-
sorptiometry in lumbar spine. 
Hypercalciuria was defined according to the following criteria:
Ca/Kg ‡4 mg; Ca/Cr >0.20 mg/mg in 24-hr urine; fasting Ca/Cr
>0.11 mg/mg (3-5).
Results
The high level of serum ionized Ca and the low value of serum
P O4 suggested primary hyperparathyroidism (PHPT). The di-
agnosis was confirmed by means of PTH and Vit D blood pro-
files and an ultrasound sonography that revealed an enlarge-
ment of the left basal parathyroid gland (Table I). 
Basal BMD was significantly lower than normal (0.775 g/cm2; T
score: –2.87; Z score: –2.27) (6,7) (Table I). 
The patient was submitted to neck surgery on January 1994
and a single parathyroid adenoma was removed (PTX). Blood
ionized Ca levels lowered immediately after surgery (1.15
mmol/l) as well as intact PTH (36 pg/mL). 
More details on mineral metabolism were obtained eight
months after PTX (September 1994); the data were compared
to those referring to pre-PTX phase (Table I). After PTX, serum
Ca, PO4, ALP, PTH levels and both fasting and daily Ca excre-
tions were restored to normal. Consequently, also bCaOx and
bbsh were reduced (4.7 vs 14.3 and 1.7 vs 5.2, respectively)
after PTX. 
Therefore, all metabolic abnormalities responsible for calcium
stone disease had reverted to normal on removal of parathy-
roid adenoma. 
Concerning medical prescriptions, daily water intake of 2 litres
at least was recommended, as well as controlled dietary in-
takes of sodium (100 mEq/day), protein (1 g/kg b.w., 50% of
which animal protein) and Ca (1000 mg/day) (8-9). 
One year later (September 1995), a relapse of hypercalciuria
was detected (fasting Ca/Cr=0.23 mg/mg and Ca/Kg =3.5 mg).
These data were confirmed in January 1996, together with nor-
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Table I - Metabolic profile before parathyroidectomy (PHPT) and
eight months after PTX.
Before PTX After PTX
Creat. Clearance (mL/min) 85 78
Serum total Ca (mg/dL) 10.4 8.7
Ionized Ca (mmol/L) 1.44 1.15
Phosphate (mg/dL) 1.7 3.1
Intact PTH (pg/mL) 121 45
ALP (mU/mL) 281 188
25 Vit D (pg/mL) 18.4 16.4
1.25 Vit D (pg/mL) 40 36.7
24 hr urine Ca (mmol)  8.8 3.5
Ca/Kg (mg)  4.5 2
Ca/Cr (mg/mg)  0.28 0.12
Fast urine Ca/Cr (mg/mg) 0.25 0.05
OHPro/Cr (mg/g) 25.8 15.1
bCaOx 14.3 4.7
bbsh 5.2 1.7
BMC (g/cm2) 0.775 –
T-score –2.87 –
Z-score –2.27 –
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mal PTH levels (38.2 pg/ml). The urinary excretion of sodium,
total nitrogen and sulphate were even lower in 1995 than in
1994; this confirmed the dietary independence of hypercalci-
uria (1) and prompted us to prescribe a daily supplement of
12.5 mg of Hydrochlorothiazide + 2.5 mg of Amiloride (10,11). 
Because of the low responsiveness of Ca excretion to such
therapy (fasting Ca/Cr=0.18 mg/mg), the drug dosages were
doubled up in January 1997. Thereafter, both daily and fasting
urinary Ca excretions returned to normal values and remained
stable until September 2003, as did the urinary supersaturation
with Ca salts (Table II).
In 2003, BMD showed a 27% increase compared to 1994.
Over the past nine years, ultrasound investigations showed
neither formation of new renal stones nor accretion of the pre-
existing ones. 
Discussion
Primary hyperparathyroidism has been reported to occur in up
to 5% of patients with idiopathic calcium stone disease. In
these subjects, hypercalciuria is considered as the main meta-
bolic abnormality leading to urinary supersaturation. Alterna-
tively, about 50% of idiopathic calcium stone formers are ex-
pected to have hyperparathyroid-independent hypercalciuria
(1). 
When our patient had the first metabolic evaluation after PTX,
both fasting and daily Ca excretion were normal. This was the
expected result of the removal of the calciuretic cause, that is,
parathyroid adenoma. Relapse of hypercalciuria appeared un-
likely unless hyperparathyroidism relapsed.
In the following year, an increase in urinary Ca was observed
even in the absence of any abnormality of both serum ionized
Ca and PTH levels. The hypercalciuria ensued from an in-
crease of fractional excretion of the filtered Ca, as suggested
by the increase of both fasting and daily Ca/Cr.
In order to explain our observations, we speculated that an in-
creased Ca deposition in bone might have lowered Ca excre-
tion for some months after surgical removal of the parathyroid
adenoma. The “hungry bone syndrome”, which frequently en-
sues from PTX for secondary hyperparathyroidism, was also
described after surgery for PHPT (12). The prevailing bone de-
position of Ca was confirmed by the 40% reduction of
OHPro/Cr in association with the reduction of both fasting and
daily urine Ca/Cr. 
When the effect of the “hungry bone” subsided hypercalciuria
relapsed, thiazides were able to restore both Ca excretion and
urine supersaturation with Ca salts. 
“Idiopathic” hypercalciuria may also occur in calcium stone for-
mers with primary hyperparathyroidism. 
The removal of parathyroid adenoma can induce a “hungry
bone syndrome” which may temporarily alter renal Ca han-
dling. Therefore, after parathyroid surgery, it is advisable to de-
lay metabolic evaluation for many months, to better define both
the actual metabolic profile and the propensity towards urinary
stone formation.
Present observations confirm that bone metabolism can play a
significant role also in the pathogenesis of idiopathic hypercal-
ciurias that are sensitive to thiazide therapy (13).
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Table II - Metabolic profile after PTX.
Years
1997 1999 2001 2003
Creat. Clearance (mL/min) 84 109 99 94
Serum   Total Ca (mg/dL) 9.1 9.9 9.4 9.5
Ionized Ca (mmol/L) 1.22 1.23 1.26 1.25
Phosphate (mg/dL) 2.9 2.3 3.4 2.4
Intact PTH (pg/mL) 38.2 48 – 51
ALP (mU/mL) 180 188 211 190
24 hr urine Ca (mmol)  4.8 2.7 3 3.8
Ca/Kg (mg)  3.1 1.5 1.7 2.2
Ca/Cr (mg/mg )  0.15 0.09 0.08 0.11
Fast urine Ca/Cr (mg/mg ) 0.18 0.07 0.05 0.04
OHPro/Cr (mg/g) 8.4 12.6 13.9 13.4
b CaOx 7.1 3.9 3 2.4
b bsh 1.1 0.9 1.7 1.6
BMC (g/cm2) 0.911 – – 1.16
T-score –1.73 – – –1.03
Z-score –1.07 – – –0.61
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